Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review.
about
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort studyReview of nonalcoholic fatty liver disease in women with polycystic ovary syndromeDiagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of EndocrinologyLipid-lowering agents in the management of nonalcoholic fatty liver diseaseNonalcoholic fatty liver disease and vascular disease: state-of-the-art.Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVOxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosisGenetic predisposition in nonalcoholic fatty liver disease.Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease.Effect of non-alcoholic fatty liver disease on carotid artery intima-media thickness as a risk factor for atherosclerosis.Inflammatory mediators of hepatic steatosis.Hepatocyte-specific IKKβ expression aggravates atherosclerosis development in APOE*3-Leiden miceAssociation between inflammatory markers and liver fat: The Multi-Ethnic Study of AtherosclerosisFactors associated with significant liver fibrosis assessed using transient elastography in general population.Knowing What's Out There: Awareness of Non-Alcoholic Fatty Liver DiseasePediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular riskHigh fat diet-induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia.The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease.Association between retinal artery lesions and nonalcoholic fatty liver diseaseEvaluation of atherosclerotic findings in patients with nonalcoholic fatty liver disease.Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease.Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase?Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver DiseaseNormal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort.Liver fat, statin use, and incident diabetes: The Multi-Ethnic Study of AtherosclerosisEpicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease.Alanine and aspartate aminotransferase and glutamine-cycling pathway: their roles in pathogenesis of metabolic syndrome.Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver diseaseEpigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET ProteinsFrom NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome?Liver fat content is negatively associated with atherosclerotic carotid plaque in type 2 diabetic patients.Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial.Heat Shock Protein 27 is down-regulated in Ballooned Hepatocytes of Patients with Nonalcoholic Steatohepatitis (NASH).Nonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survival.De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucoseLiver fat and SHBG affect insulin resistance in midlife women: the Study of Women's Health Across the Nation (SWAN).Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primatesRelationship between aspartate aminotransferase-to-platelet ratio index and carotid intima-media thickness in obese adolescents with non-alcoholic fatty liver disease.Nonalcoholic fatty liver disease and cardiovascular risk.Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome.
P2860
Q24596256-5788130C-9BFA-43C6-AAFF-91617A504053Q26828765-D915165C-15DA-4DD0-903D-6AACAAF2D4B1Q26998471-6321B9BE-8077-4FA8-958F-62BD705C67ADQ27024352-4AE89DE5-A0D9-4715-9556-BA389011D915Q27692035-16763BA3-A9BA-4AE4-AEE8-FB18B6865082Q28079826-C5737535-BAA4-462E-9F51-82F733EC6ACFQ28084150-DA72A5BF-94CC-4302-8E69-F17D512C5BD2Q30235398-05149AB0-2047-477A-8298-C333188B8ECCQ30435948-5A9C00C6-2269-4B28-8BB7-056AC3E74361Q33596784-CD0978C3-3EEE-4C22-9924-DF67954E304DQ33734136-CFCBB3F6-8F68-4472-9F5E-BA6EC3C827A2Q33898304-8EEFBBDD-7905-45A7-BB87-20592EBB2F56Q34976232-9E2EAB6F-F4E2-4D66-9E55-7C76438B836EQ35012048-FEAFAEE4-FF4C-464E-9465-94B9FBFDF448Q35153538-A54460F8-6328-467A-A0C5-268F95DB1F20Q35171570-7D2F9C4B-F0D4-4D6E-AEC3-9677DBCDC648Q35216069-81810D9D-C628-4311-91FA-734FF135510CQ35216649-B4B7C10C-E4DA-49FC-A572-069218D82BF0Q35289060-799E43C7-ED57-456B-BA21-F90E87AB2B04Q35560585-E10CC8D9-5A52-4EF9-AE87-CAF5CB71141AQ35602513-910C070F-3948-40B4-971D-B0DEBF6F4028Q35927865-780F1BBA-E8B7-4BFA-8B1C-4502B589895DQ35947534-1773C773-859C-4F80-BC4B-CC85FE888F12Q35948791-6044F4AA-9140-4DE2-BBEA-5F66D673B486Q35988594-9CFC2ACA-3AE5-4B3B-92AE-C316B11EBDA7Q36132807-9D018FBE-17BC-460A-997A-9C2519B453DBQ36144444-F4895333-969B-4D50-A334-7BF702F3F4D2Q36151646-FA9F6AE6-41B0-48DB-8519-1184753B0C1EQ36194904-00A8CB15-6FD4-4253-8F47-AFE065D977EEQ36207195-39A26FF2-A176-4558-85F0-5328E2A28957Q36427402-F713E47A-D5E4-4F64-AF06-911A382AA118Q36569181-9072BC95-7130-4F02-86D4-4C213EB2D8AEQ36645256-6486913E-633D-4FEE-AB9F-C1C67A217C5CQ36673799-FD634D3D-4E1F-409C-B0F0-DED10FA2B64DQ36800168-37E8DB3C-DC4C-4BFD-AC01-967CDD95E519Q36962820-1C5EBF3F-7781-4802-8C4E-343AB2AB08ABQ37016475-98933185-BA55-4AD6-AC9B-DFBD60ED6029Q37270922-13DC45D8-4A57-4DAC-85B4-C4D26ECEFAF1Q37318761-586F14E4-AF3C-4ADA-A204-A512729BFFFDQ37358279-1804F325-9881-42E2-A814-7A30D7E947E1
P2860
Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non-alcoholic fatty liver dise ...... clerosis: a systematic review.
@en
Non-alcoholic fatty liver dise ...... clerosis: a systematic review.
@nl
type
label
Non-alcoholic fatty liver dise ...... clerosis: a systematic review.
@en
Non-alcoholic fatty liver dise ...... clerosis: a systematic review.
@nl
prefLabel
Non-alcoholic fatty liver dise ...... clerosis: a systematic review.
@en
Non-alcoholic fatty liver dise ...... clerosis: a systematic review.
@nl
P1476
Non-alcoholic fatty liver dise ...... clerosis: a systematic review.
@en
P2093
Silvia Sookoian
P304
P356
10.1016/J.JHEP.2008.06.012
P577
2008-07-02T00:00:00Z